Cite
HARVARD Citation
Yamasaki, S. et al. (2020). Phase II study of dose‐adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B‐cell lymphoma patients. EJHaem. 1 (2), pp. 507-516. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yamasaki, S. et al. (2020). Phase II study of dose‐adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B‐cell lymphoma patients. EJHaem. 1 (2), pp. 507-516. [Online].